Literature DB >> 32178558

LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.

Jun Gao1, Chao Dai1, Xin Yu1, Xiang-Bao Yin1, Fan Zhou1.   

Abstract

Hepatocellular carcinoma (HCC) is recognized for its high mortality rate worldwide. Based on intensive studies, long non-coding RNA (lncRNA) expression exerts significant effects on tumor suppression. Herein, we investigated the molecular mechanism of lymphoid enhancer-binding factor-1 antisense RNA 1 (LEF1-AS1) in HCC cells. Microarray-based gene expression analysis was adopted to predict and verify the differentially expressed genes in HCC, which predicted cell division cycle-associated 7 (CDCA7) and LEF1-AS1 to be highly expressed in HCC. The expression of LEF1-AS1, CDCA7, CCAAT/enhancer-binding protein beta (CEBPB) and enhancer of zeste homolog 2 (EZH2) was determined by means of reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blot analysis. LncMap was used to predict the lncRNA-transcription factor-gene interaction in HCC. ChIP, RIP assay and dual luciferase reporter gene assay were employed to verify the relationship between the transcription factor and gene. Silencing of LEF1-AS1 could downregulate CDCA7 expression through CEBPB. Overexpression of LEF1-AS1, EZH2 and CDCA7 promoted proliferation and invasion in HCC cells. LEF1-AS1 promoted CDCA7 expression to further upregulate EZH2. Tumor formation in nude mice was assessed to verify the experimental results. Silencing of LEF1-AS1 inhibited the growth of tumors in vivo. Collectively, silencing LEF1-AS1 inhibited the proliferation and invasion of HCC cells by down-regulating EZH2 through the CEBPB-CDCA7 signaling pathway, which provides scientific evidence for the treatment of HCC.Abbreviations: HCC: Hepatocellular carcinoma; lncRNA: long non-coding RNA; LEF1-AS1: lymphoid enhancer-binding factor-1 antisense RNA 1; EZH2: enhancer of zeste homolog 2; CDCA7: cell division cycle-associated 7; GEO: Gene Expression Omnibus; NC: negative control; oe: overexpressed; RT-qPCR: reverse transcription quantitative polymerase chain reaction; PBS: phosphate buffered saline; HRP: horseradish peroxidase; OD: optical density; RIP: Radioimmunoprecipitation; ChIP: Chromatin immunoprecipitation; WT: wild type.

Entities:  

Keywords:  CDCA7; CEBPB; EZH2; LEF1-AS1; hepatocellular carcinoma; invasion; proliferation; transcription factor

Year:  2020        PMID: 32178558      PMCID: PMC7217375          DOI: 10.1080/15384101.2020.1731052

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

1.  The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.

Authors:  Rebecca C Osthus; Baktiar Karim; Julia E Prescott; B Douglas Smith; Michael McDevitt; David L Huso; Chi V Dang
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

2.  Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.

Authors:  Jin-feng Huang; Ying-jun Guo; Chen-xi Zhao; Sheng-xian Yuan; Yue Wang; Guan-nan Tang; Wei-ping Zhou; Shu-han Sun
Journal:  Hepatology       Date:  2013-05       Impact factor: 17.425

3.  The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation.

Authors:  R Montgomery Gill; Timothy V Gabor; Amber L Couzens; Michael P Scheid
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

4.  LncRNAs and cancer.

Authors:  Rui Zhang; Li Qiong Xia; Wen Wen Lu; Jing Zhang; Jin-Shui Zhu
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967

5.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

Authors:  Kornelius Schulze; Sandrine Imbeaud; Eric Letouzé; Ludmil B Alexandrov; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Clément Meiller; Jayendra Shinde; Frederic Soysouvanh; Anna-Line Calatayud; Roser Pinyol; Laura Pelletier; Charles Balabaud; Alexis Laurent; Jean-Frederic Blanc; Vincenzo Mazzaferro; Fabien Calvo; Augusto Villanueva; Jean-Charles Nault; Paulette Bioulac-Sage; Michael R Stratton; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

6.  Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).

Authors:  Renumathy Dhanasekaran; Meital Gabay-Ryan; Virginie Baylot; Ian Lai; Adriane Mosley; Xinqiang Huang; Sonya Zabludoff; Jian Li; Vivek Kaimal; Priya Karmali; Dean W Felsher
Journal:  Oncotarget       Date:  2017-11-09

Review 7.  Long non-coding RNAs in ovarian cancer.

Authors:  Lei Zhan; Jun Li; Bing Wei
Journal:  J Exp Clin Cancer Res       Date:  2018-06-19

8.  LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer.

Authors:  Ansheng Wang; Chengling Zhao; Yuan Gao; Guixin Duan; Yuming Yang; Bo Fan; Xiaojing Wang; Kangwu Wang
Journal:  Invest New Drugs       Date:  2019-02-08       Impact factor: 3.850

9.  C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation.

Authors:  Dan Liu; Xiao-Xue Zhang; Meng-Chen Li; Can-Hui Cao; Dong-Yi Wan; Bi-Xin Xi; Jia-Hong Tan; Ji Wang; Zong-Yuan Yang; Xin-Xia Feng; Fei Ye; Gang Chen; Peng Wu; Ling Xi; Hui Wang; Jian-Feng Zhou; Zuo-Hua Feng; Ding Ma; Qing-Lei Gao
Journal:  Nat Commun       Date:  2018-04-30       Impact factor: 14.919

10.  Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers.

Authors:  Goodwin G Jinesh; Elsa R Flores; Andrew S Brohl
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

View more
  9 in total

1.  The Transcription Factor C/EBPβ Promotes HFL-1 Cell Migration, Proliferation, and Inflammation by Activating lncRNA HAS2-AS1 in Hypoxia.

Authors:  Xue Yang; Fei Qi; Shanchen Wei; Lianjun Lin; Xinmin Liu
Journal:  Front Cell Dev Biol       Date:  2021-03-12

2.  Long Non-Coding LEF1-AS1 Sponge miR-5100 Regulates Apoptosis and Autophagy in Gastric Cancer Cells via the miR-5100/DEK/AMPK-mTOR Axis.

Authors:  Huimin Zhang; Jun Wang; Yundan Wang; Jiapeng Li; Lili Zhao; Tongcun Zhang; Xinghua Liao
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

Review 3.  Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma.

Authors:  Mohamed H Yousef; Hassan A N El-Fawal; Anwar Abdelnaser
Journal:  Biomed Res Int       Date:  2020-11-24       Impact factor: 3.411

Review 4.  Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors.

Authors:  Qingyuan Zheng; Xiao Yu; Menggang Zhang; Shuijun Zhang; Wenzhi Guo; Yuting He
Journal:  Front Cell Dev Biol       Date:  2021-12-20

5.  Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.

Authors:  Yang Luo; Yue Zhang; Yu-Xin Wu; Han-Bing Li; Di Shen; Yi-Qun Che
Journal:  J Clin Lab Anal       Date:  2021-12-11       Impact factor: 2.352

6.  LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer.

Authors:  Shuyan Yang; Jing Wang; Rongjie Cheng; Bo Pang; Pengcheng Sun
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-11       Impact factor: 2.629

7.  Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation.

Authors:  Kaku Goto; Hironori Nishitsuji; Masaya Sugiyama; Nao Nishida; Masashi Mizokami; Kunitada Shimotohno
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

8.  Single-Cell RNA Sequencing Reveals the Role of Phosphorylation-Related Genes in Hepatocellular Carcinoma Stem Cells.

Authors:  Fuwen Yao; Yongqiang Zhan; Changzheng Li; Ying Lu; Jiao Chen; Jing Deng; Zijing Wu; Qi Li; Yi'an Song; Binhua Chen; Jinjun Chen; Kuifeng Tian; Zuhui Pu; Yong Ni; Lisha Mou
Journal:  Front Cell Dev Biol       Date:  2022-01-04

9.  Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.

Authors:  Xinyi Lei; Miao Zhang; Bingsheng Guan; Qiang Chen; Zhiyong Dong; Cunchuan Wang
Journal:  Hum Genomics       Date:  2021-06-29       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.